Resveratrol inhibits the deleterious effects of diet-induced obesity on thymic function

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1625-1633

  Gulvady, Apeksha A ^a   Ciolino, Henry P ^b   Cabrera, Robert M ^a   Jolly, Christopher A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Diet; Mouse; Obesity; Resveratrol; T cell; Thymus

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; GENOMIC DNA; RESVERATROL; T LYMPHOCYTE RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; CATALYSIS; CELL MATURATION; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIET; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MOUSE; NONHUMAN; OBESITY; PHYTOCHEMISTRY; T LYMPHOCYTE; THYMOCYTE; THYMUS FUNCTION; WESTERN BLOTTING;

MUS;

EID: 84881550263     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.02.003     Document Type: Article

References (27)

1. Haynes B.F., Sempowski G.D., Wells A.F., Hale L.P. The human thymus during aging. Immunol Res 2000, 22:253-261.
2. Louie J.K., Acosta M., Samuel M.C., Schechter R., Vugia D.J., Harriman K., Matyas B.T. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011, 52:301-312.
3. Karlsson E.A., Beck M.A. The burden of obesity on infectious disease. Exp Biol Med 2010, 235:1412-1424.
4. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010, 184:3127-3133.
5. Yang H., Youm Y.-H., Vandanmagsar B., Rood J., Kumar K.G., Butler A., Dixit V.D. Obesity accelerates thymic aging. Blood 2009, 114:3803-3812.
6. Yang H., Youm Y.-H., Dixit V.D. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol 2009, 183:3040-3052.
7. Ogden C.L., Carroll M.D., Curtin L.R., Lamb M.M., Flegal K.M. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
8. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserve P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
9. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
10. Timmers S., Konings E., Bilet L., Houtkooper R.H., van de Weijer T., Goossens G.H., Hoeks J., van der Krieken S., Ryu D., Kersten S., Moonen-Kornips E., Hesselink M.K.C., Kunz I., Schrauwen-Hinderling V.B., Blaak E.E., Auwerx J., Schrauwen P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011, 14:612-622.
11. Lim B.O., Jolly C.A., Zaman K., Fernandes G. Dietary (n-6) and (n-3) fatty acids and energy restriction modulate mesenteric lymph node lymphocyte function in autoimmune-prone (NZB x NZW)F1 mice. J Nutr 2000, 130:1657-1664.
12. Jolly C.A., Fernandes G. Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice. J Clin Immunol 1999, 19:172-178.
13. Ribeiro R.M., Perelson A.S. Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data. Immunol Rev 2007, 216:21-34.
14. Collison L.W., Jolly C.A. Phosphorylation regulates mitochondrial glycerol-3-phosphate-1 acyltransferase activity in T-lymphocytes. Biochim Biophys Acta 2006, 1761:129-139.
15. Barger J.L., Kayo T., Vann J.M., Arias E.B., Wang J., Hacker T.A., Wang Y., Raederstorff D., Morrow J.D., Leeuwenburgh C., Allison D.B., Saupe K.W., Cartee G.D., Weindruch R., Prolla T.A. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008, 3:e2264.
16. Steinmann G.G., Klaus B., Müller-Hermelink H.K. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985, 22:563-575.
17. Harikumar K.B., Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
18. Kovacic P., Somanathan R. Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev 2010, 3:86-100.
19. Shukla Y., Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann NY Acad Sci. 2011, 1215:1-8.
20. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci 2007, 104:7217-7222.
21. Eliakim A., Schwindt C., Zaldivar F., Casali P., Cooper D.M. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006, 39(2):137-141.
22. Bresnahan M.R., Newberne P.M. Interaction of diet and distemper virus infection on lipid metabolism in the dog. Br J Exp Pathol 1968, 49(3):223-234.
23. Feng Y.H., Zhou W.-L., Wu Q.-L., Xo-Y Li, Zhao W.-M., Zou J.-P. Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol Sin 2002, 23(10):893-897.
24. Yang Y., Paik J.H., Cho D., Cho J.A., Kim C.W. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int Immunopharm 2008, 8(4):542-547.
25. Zhang J., Lee S.M., Shannon S., Gao B., Chen W., Chen A., Divekar R., McBurney M.W., Braley-Mullen H., Zaghouani H., Fang D. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 2009, 119(10):3048-3058.
26. Aspinall R., Mitchell W. Reversal of age-associated thymic atrophy: treatments, delivery, and side effects. Exp Gerontol 2008, 43:700-705.
27. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.